NRTX 381 : Description: Music City Star commuter train 156 shoves past the former Tennessee Central depot in Lebanon (now an office for the Nashville & Eastern) Photo Date: 10/25/2013 Upload Date: 10/28/2013 3:36:19 PM : Location: Lebanon, TN : Author: John Higginson: Categories: Station: Locomotives: NRTX 381(F40PH) Views: 358 Comments: 0

It was sold as Tennessee Regional Transportation Authority as NRTX 381 in 2006. 568, B40-8W, was built by General Electric in March 1992, #46914, as Atchison Topeka & Santa Fe 568, Class 500. It became Burlington Northern Santa Fe 568, Class Dash8-40BW, in March 2003 and retired on October 12, 2010.

Other locos with this serial: CNRY 381(F40PHR) AMTK 381(F40PHR) NERR 381(F40PH) NRTX 381(F40PH) Page Controls : View: Pics Per Page: Title: Auto Train arrives : Description: The Auto Train behind a pair of F40s I had seen in Washington that previous Saturday arrives at Sanford. Photo Date: 5/6/1985 ...

The WeGo Star (reporting mark NRTX), formerly the Music City Star, is a commuter rail service running between Nashville and Lebanon, Tennessee. The service uses the existing track of the Nashville and Eastern Railroad. The line stops at seven stations: Riverfront (Nashville), Donelson, Hermitage, Mt. Juliet, Martha, Hamilton Springs and Lebanon ...

Locomotives: NRTX 381(F40PH) Author: Dennis Mize: Picture Categories: Roster,Yard,Passenger: This picture is part of album: Nashville & Eastern: Share User Comments No Comments on this picture. Add a Comment: Please Log in to leave a Comment.

2025年1月29日 · FLAV-381 [Uncensored Leaked] HYPER FETISH High-leg Erotic Queen Nami Kuroki Date: January 29, 2025 Time: 02:30:00 Pornstars: Nami Kuroki

High quality photograph of Music City Star EMD F40PH # NRTX 381 at Mt. Juliet, Tennessee, USA.

近日，Neurona Therapeutics公布了其来源于人诱导多能干细胞（iPSC）的一种神经元细胞治疗药物NRTX-1001用于治疗内侧颞叶癫痫（MTLE）的1/2期临床试验最新数据。

2025年3月13日 · 2025年2月20日，Neurona Therapeutics宣布，其创新性再生细胞疗法NRTX-1001将于2025年下半年启动关键性III期EPIC试验（EPIlepsy Cell Therapy）。 该试验为随机、假手术对照、双盲研究，旨在评估NRTX-1001对耐药性内侧颞叶癫痫（MTLE）的疗效。 这个III期试验的结果，将与正在进行的 I/II期试验的结果一起，有力的支持NRTX-1001的上市申请。 耐药性癫痫患者面临持续癫痫发作的重大风险，现有的治疗选择有限，如手术切除或消融癫痫灶，可能 …

2023年10月11日 · 10月5日，Neurona Therapeutics宣布在 Cell Stem Cell 上发表论文，报道了 针对耐药性局灶性癫痫的新型再生细胞治疗 策略的研究进展，该研究证明了NRTX-1001具有良好的稳健性和可重复性， NRTX-1001是衍生自人类干细胞系的高度纯化的大脑皮层MGE型（内侧神经节隆起）GABA能 ...